Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice

Trial Profile

Physical Activity in Patients With Rheumatoid Arthritis Treated With Adalimumab in Routine Clinical Practice

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2017

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms PACE
  • Sponsors Abbott Laboratories; AbbVie
  • Most Recent Events

    • 17 Jun 2017 Results assessing effect of adalimumab treatment on physical activity and relationship with improvements in disease activity presented at the 18th Annual Congress of the European League Against Rheumatism.
    • 20 Nov 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
    • 17 Feb 2015 Planned number of patients changed from 550 to 1000 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top